{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:21:35Z","timestamp":1788870095326,"version":"build-2803163510"},"reference-count":84,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"Roche"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.2217\/imt.13.174","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T11:58:07Z","timestamp":1398340687000},"page":"333-348","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Current and Future Therapeutic Approach for Waldenstr\u00f6m\u2019s Macroglobulinemia"],"prefix":"10.1080","volume":"6","author":[{"given":"Laetitia","family":"Souchet-C\u00f6mpain","sequence":"first","affiliation":[{"name":"Service d\u2019H\u00e9matologie,Pavillon de l\u2019enfant et de l\u2019adolescent,\rGroupe hospitalier Piti\u00e9 Salp\u00eatri\u00e8re,\r47\u201383 boulevard de l\u2019h\u00f4pital,\r75651\rParis Cedex 13,\rFrance"},{"name":"UPMC Universit\u00e9 Paris 6,GRC n\u00b0II,GRECHY,\rF-75013,\rParis,\rFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Choquet","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie,Pavillon de l\u2019enfant et de l\u2019adolescent,\rGroupe hospitalier Piti\u00e9 Salp\u00eatri\u00e8re,\r47\u201383 boulevard de l\u2019h\u00f4pital,\r75651\rParis Cedex 13,\rFrance"},{"name":"UPMC Universit\u00e9 Paris 6,GRC n\u00b0II,GRECHY,\rF-75013,\rParis,\rFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Leblond","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie,Pavillon de l\u2019enfant et de l\u2019adolescent,\rGroupe hospitalier Piti\u00e9 Salp\u00eatri\u00e8re,\r47\u201383 boulevard de l\u2019h\u00f4pital,\r75651\rParis Cedex 13,\rFrance"},{"name":"UPMC Universit\u00e9 Paris 6,GRC n\u00b0II,GRECHY,\rF-75013,\rParis,\rFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie,Pavillon de l\u2019enfant et de l\u2019adolescent,\rGroupe hospitalier Piti\u00e9 Salp\u00eatri\u00e8re,\r47\u201383 boulevard de l\u2019h\u00f4pital,\r75651\rParis Cedex 13,\rFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.017251"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50082"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2011.n.021"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200710"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-475111"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-436329"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-084525"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50071"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-005488"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-174961"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-172080"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50038"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50037"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12102"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01918.x"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.7920"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.546"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000185"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.41"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.10.1928.1928"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-3-199302010-00007"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1995.tb01779.x"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.6.2060"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.9.2640"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-3-199302010-00007"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.12.2694"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050247"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01069.x"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.1331f.x"},{"key":"e_1_3_2_35_1","first-page":"740","article-title":"2-Chlorodeoxyadenosine treatment of Waldenstr\u00f6m\u2019s macroglobulinemia \u2013 the analysis of own experience and the review of literature","volume":"6","author":"Lewandowski K","year":"2000","unstructured":"Lewandowski K, Zaucha JM, Bieniaszewska M, Halaburda K, Hellmann A. 2-Chlorodeoxyadenosine treatment of Waldenstr\u00f6m\u2019s macroglobulinemia \u2013 the analysis of own experience and the review of literature. Med. Sci. Monit. 6, 740\u2013745 (2000).","journal-title":"Med. Sci. Monit."},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50070"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.1530"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200105000-00012"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190410001714043"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.039"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2002.n.022"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi022"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2005.n.014"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.059"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08750.x"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20658"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181f2caef"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e32834da987"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21818"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.3701.3701"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-338558"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2013.04.006"},{"key":"e_1_3_2_53_1","first-page":"8","volume-title":"American society of Hematology Annual Meeting","author":"Le Garff-Tavernier M","year":"2012","unstructured":"Le Garff-Tavernier M Herbi L de Romeuf C et al. Ublituximab, an optimized anti-CD20 monoclonal antibody, demonstrates greater NK-mediated ADCC than rituximab in Waldenstr\u00f6m\u2019s macroglobulinemia patients supporting a therapeutic strategy with ublituximab. Presented at: American society of Hematology Annual Meeting. Atlanta, GA, USA, 8\u201311 December 2012."},{"key":"e_1_3_2_54_1","first-page":"1655","article-title":"Treatment of relapsed or refractory Waldenstr\u00f6m\u2019s macroglobulinemia with bortezomib","volume":"90","author":"Dimopoulos MA","year":"2005","unstructured":"Dimopoulos MA, Anagnostopoulos A, Kyrtsonis MC, Castritis E, Bitsaktsis A, Pangalis GA. Treatment of relapsed or refractory Waldenstr\u00f6m\u2019s macroglobulinemia with bortezomib. Haematologica 90, 1655\u20131658 (2005).","journal-title":"Haematologica"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2511"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.8659"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2011.n.030"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.16.3596"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1837"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0181"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.0994"},{"key":"e_1_3_2_62_1","first-page":"8","volume-title":"American Society Of Hematology Annual Meeting","author":"Ghobrial IM","year":"2012","unstructured":"Ghobrial IM, Siegel D, Vij R et al. MLN0128 (INK128), an investigational oral dual TORC1\/2 inhibitor, inp atients (pts) with relapsed or refractory multiple myeloma (MM), non-Hodgkin\u2019s lymphoma (NHL), or Waldenstr\u00f6m macroglobulinemia (WM): preliminary results from a Phase 1 dose-escalation study. Presented at: American Society Of Hematology Annual Meeting. Atlanta, GA, USA, 8\u201311 December 2012."},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-439307"},{"key":"e_1_3_2_64_1","first-page":"3580","article-title":"DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine","volume":"7","author":"Yamauchi T","year":"2001","unstructured":"Yamauchi T, Nowak BJ, Keating MJ, Plunkett W. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clin. Cancer Res. 7, 3580\u20133589 (2001).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403885"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190903349688"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.5.1765.h81702001765_1765_1773"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.261"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.10.9926"},{"key":"e_1_3_2_70_1","first-page":"8","volume-title":"American Society Of Hematology Annual Meeting","author":"Dimopoulos MA","year":"2012","unstructured":"Dimopoulos MA, Maria Roussou M, Kastritis E et al. Primary treatment of Waldenstr\u00f6m\u2019s macroglobulinemia with dexamethasone, rituximab and cyclophosphamide (DRC): final analysis of a Phase II study. Presented at: American Society Of Hematology Annual Meeting. Atlanta, GA, USA, 8\u201311 December 2012."},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.016"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-177329"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.6315"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21882"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26303"},{"key":"e_1_3_2_76_1","first-page":"10","volume-title":"The Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019H\u00e9matologie Annual Meeting","author":"Compain L","year":"2011","unstructured":"Compain L,Levy V, Tamburini J et al. Fludarabine plus cyclophosphamide and rituximab (FCR) in Waldenstr\u00f6m\u2019s macroglobulinemia: results in 62 patients. Presented at: The Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019H\u00e9matologie Annual Meeting. Paris, France, 10\u201312 March 2011."},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-150854"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0862"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.4677"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21788"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.3237"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-503862"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.4905"},{"key":"e_1_3_2_85_1","unstructured":"Kuiatse I Thomas S Weber D et al. Inhibition of spleen tyrosine kinase with fostamatinib shows pre-clinical activity against models of Waldenstr\u00f6m macroglobulinemia. Presented at: American Society Of Hematology Annual Meeting Atlanta GA USA 8\u201311 December 2012."},{"key":"e_1_3_2_86_1","first-page":"23","volume-title":"IWWM-7","author":"Yang G","year":"2012","unstructured":"Yang G Liu X Zhou YS et al. Targeting Waldenstr\u00f6m macroglobulinemia with MYD88 and IRAK inhibitors. Presented at: IWWM-7, Newport, RI, USA, 23\u201326 August 2012."},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.7865"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.087213"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.13.174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T07:01:13Z","timestamp":1715929273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.13.174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.2217\/imt.13.174"],"URL":"https:\/\/doi.org\/10.2217\/imt.13.174","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-04-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}